Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 695501 vs Humira in chronic plaque psoriasis
NCT02850965Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2016
- Primary completion
- Jan 2018
- Modality
- Monoclonal Antibodies
- Countries
- 8
01
Overview
A Phase 3 trial of adalimumab in plaque psoriasis, sponsored by Boehringer Ingelheim. Started Aug 2016; status: completed.
02
Drugs
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02850965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02850965.